Table 1.
Clinical and echocardiographic characteristics of acromegalic patients.
| Patients | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Variables | ||||||||
| Age (ys) | 37 | 30 | 49 | 31 | 69 | 55 | 57 | 47 |
| Sex | M | M | M | F | F | M | M | M |
| BSA (g/m2)|| | 1.95 | 1.99 | 2.03 | 2.27 | 1.68 | 2.11 | 2.10 | 2.11 |
| Presumed disease duration (ys) | 7 | 2 | 4 | 4 | 10 | 1 | 2 | 4 |
| IGF-1 at biopsy (ng/ml) † | 1241 | 1205 | 634 | 952 | 657 | 938 | 938 | 787 |
| LVEF (%)** | 54 | 58 | 56 | 60 | 50 | 50 | 52 | 55 |
| MWT (mm)‡ | 14 | 13 | 10 | 11 | 13 | 14 | 16 | 13 |
| LV mass index (g/m2) ¶ | 151 | 132 | 88 | 103 | 143 | 132 | 160 | 136 |
BSA=Body surface area;
IGF -1=Insulin-like growth factor 1, normal range=80–330 ng/ml;
LV=Left ventricular, EF=Ejection Fraction;
MWT=maximal wall thickness;
LV mass index calculated according to Devereux36, normal values 91±20 g/m2.